Susquehanna International Group
TNXP icon

Susquehanna International Group’s Tonix Pharmaceuticals TNXP Stock Holding History

Susquehanna International Group’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$549K Buy
43,034
+13,455
+45% +$174K ﹤0.01% 9695
2026
Q1 		$407K Sell
29,579
-83
-0.3% -$1.28K ﹤0.01% 10166
2025
Q4 		$463K Buy
29,662
+20,912
+239% +$386K ﹤0.01% 8974
2025
Q3 		$211K Sell
8,750
-258
-3% -$9.57K ﹤0.01% 10878
2025
Q2 		$324K Buy
+9,008
New +$236K ﹤0.01% 10164
2022
Q2 		– Hold
0
– -$6K – 13949
2022
Q1 		– Hold
0
– – – 12804
2021
Q4 		– Hold
0
– – – 12605
2021
Q2 		– Sell
-1
Closed -$1.01M – 13265
2021
Q1 		$1.01M Buy
+1
New +$765K ﹤0.01% 7713
2020
Q3 		– Hold
0
– -$13K – 11150
2020
Q2 		– Hold
0
– – – 9960
2020
Q1 		– Hold
0
– – – 10078
2019
Q4 		– Hold
0
– -$11K – 10647
2019
Q3 		– Hold
0
– – – 10011
2019
Q2 		– Hold
0
– – – 10041
2018
Q3 		– Hold
0
– -$220K – 10244
2018
Q2 		– Hold
0
– – – 8445
2017
Q4 		– Hold
0
– -$207K – 9906
2017
Q3 		– Hold
0
– – – 7966
2017
Q2 		– Hold
0
– – – 7113
2017
Q1 		– Hold
0
– – – 5635
2016
Q4 		– Hold
0
– – – 9486
2016
Q3 		– Hold
0
– – – 8260
2015
Q4 		– Hold
0
– – – 9983
2015
Q3 		– Hold
0
– – – 8909
2014
Q4 		– Hold
0
– -$147K – 10102
2014
Q3 		– Hold
0
– – – 8905

Other funds holding TNXP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
II
Ishara Investments Los Angeles, California $136M AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Susquehanna International Group's TNXP Position: Q2 2026 in Review

Susquehanna International Group increased its Tonix Pharmaceuticals (TNXP) stake by 45% in Q2 2026, buying an estimated $174K and bringing the position to 43,034 shares worth $549K. The position accounts for ﹤0.01% of the portfolio, ranked #9695.

Susquehanna International Group first reported a position in TNXP in Q1 2021 and has held it in 6 quarters since. The position peaked at $1.01M in Q1 2021. 102 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • Susquehanna International Group held 43,034 shares of Tonix Pharmaceuticals worth $549K as of Q2 2026.
  • Susquehanna International Group bought 13,455 Tonix Pharmaceuticals shares in Q2 2026, an estimated $174K.
  • Tonix Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #9695 holding.
  • Susquehanna International Group first reported a position in Tonix Pharmaceuticals in Q1 2021 and has held it in 6 quarters since.
  • Susquehanna International Group's Tonix Pharmaceuticals position peaked at $1.01M in Q1 2021.
  • 102 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.